BFRI Wutah bathi saben saham ing taun iki Biofrontera Inc

BFRI (Biofrontera Inc.) - tandha merek perusahaan

Biofrontera Inc. (BFRI) is implementing updated Ameluz lamps, expanding the list of dermatological indications. The annual earnings per share growth vector demonstrates market dynamics, where the current level is around 62.30. A "razor-and-blade" model ensures recurring revenue from gel sales. A monopoly in the treatment of precancerous conditions in the US is supported by the synergy of proprietary software and light systems.

BFRI: Wutah bathi ing taun lumaku Biofrontera Inc. 04.07.2022 - 10.11.2026

Rincian metrik keuangan lan pasar biofrontera-us.com (BFRI)

- kuotasi saiki lan rata-rata prakiraan nilai:
Bagan bursa Biofrontera|BFRI - Bagan rega target
- data kapitalisasi pasar:
Kapitalisasi pasar Biofrontera|BFRI - Nilai Perusahaan
- informasi kapitalisasi buku:
Aset Bersih saben Siji Saham Biofrontera|BFRI - Kapitalisasi Buku|Kapitalisasi Pasar marang Nilai Buku biofrontera-us.com|BFRI - Aset Agregat Perusahaan
- indikator beban utang lan likuiditas:
Utang marang Modal Biofrontera Inc.|BFRI - Utang jangka dawa marang modal|Kewajiban jangka cendhak marang ekuitas Biofrontera|BFRI - Utang perusahaan|Rasio utang marang aset resik Biofrontera|BFRI - Utang jangka dawa perusahaan|Utang jangka cendhak Biofrontera|Rasio likuiditas darurat biofrontera-us.com
- informasi bathi lan kelipatan valuasi:
BFRI - Penghasilan resik|Bathi resik mangsa ngarep Biofrontera Inc.|BFRI - Pangali P/E|Rasio prakiraan rega marang bathi Biofrontera|BFRI - Rasio rega marang bathi tumrap wutah|Nilai bisnis marang bathi operasional sadurunge panyusutan Biofrontera|BFRI - Bathi operasional EBITDA|Bathi resik saben saham (EPS TTM) Biofrontera|BFRI - Bathi resik saben saham sajrone 12 wulan pungkasan|Wutah bathi saben siji saham taun-ka-taun sajrone 12 wulan pungkasan biofrontera-us.com|BFRI - Wutah bathi ing taun lumaku|Prakiraan konsensus wutah bathi saben saham kanggo taun ngarep Biofrontera Inc.
Analisis dhasar perusahaan:Biofrontera Inc (BFRI)
Produk mawa merek biofrontera-us.com

This indicator measures the year-over-year dynamics of earnings per share, reflecting operational management efficiency and the business's ability to generate income. A negative trajectory for this metric signals risks of asset impairment and declining profitability. By analyzing the annual EPS growth rate, an investor can see how the proprietary photodynamic therapy and complex FDA barriers translate into real financial results for Biofrontera Inc. (BFRI).

Pesaing utama

KRYS - Prakiraan wutah bathi resik saben saham ing taun iki|Wutah bathi saben saham ing taun lumaku Apogee Pharma|Wutah bathi saben saham ing taun iki ARQT (Arcutis Corp)|Wutah bathi ing taun lumaku VCEL|Wutah bathi saben saham ing taun lumaku ORKA (orukatx.com)|Wutah bathi ing taun lumaku SMTI (Sanara MedTech)|Prakiraan wutah bathi resik saben saham ing taun iki DBV Tech (DBVT)|SLSN - Wutah bathi saben saham ing taun lumaku|Kacepetan wutah bathi saben saham ing taun lumaku Journey Medical|FBRX: Wutah bathi ing taun lumaku|Dinamika bathi saben saham ing taun lumaku EMPG (empro.my)|Wutah bathi saben saham ing taun lumaku Sol-Gel Technologies Ltd.|AXIL: Tambahing bathi saben saham ing taun lumaku|Wutah bathi saben saham ing taun lumaku Medicus Pharma Limited (MDCX)|VRCA - Kacepetan wutah bathi saben saham ing taun lumaku|Wutah bathi saben saham ing taun lumaku Hoth Therapeutics HOTH|VYNE: Wutah bathi saben saham ing taun iki|SNOA: Wutah bathi resik saben saham ing taun iki|Quoin Pharmaceuticals - Wutah bathi resik saben siji saham kanggo taun lumaku|AZTR: Wutah bathi ing taun lumaku|Kacepetan wutah bathi saben saham ing taun lumaku Dermata Corp (DRMA)|Wutah bathi saben saham ing taun lumaku Elevai Labs Inc.|RVNC: Tambahing bathi saben saham ing taun lumaku